Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07805785) titled 'A Study to Assess the Efficacy and Safety of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Progressive Pulmonary Fibrosis (PPF)' on Sept. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Insmed Incorporated
Condition:
Progressive Pulmonary Fibrosis
Interstitial Lung Disease
Intervention:
Drug: Treprostinil Palmitil Inhalation Powder
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enro...